You are here: Industry Insights > vaccine

News List

Open letter calls for UK government to stop pharma profiting from COVID-19 europeanpharmaceuticalreview
April 20, 2020
An open letter from aid organisations and academics has called on the UK government to stipulate conditions for pharmaceutical companies using public funding for COVID-19 vaccines.
University of Waterloo to develop nasal vaccine for Covid-19 pharmaceutical-technology
April 20, 2020
University of Waterloo researchers in Canada are developing a DNA-based vaccine candidate that can be given via nasal route to protect from Covid-19 infection.
US BARDA commits up to $483m for Moderna Covid-19 vaccine pharmaceutical-technology
April 20, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) has committed up to $483m to support the development of the Moderna mRNA vaccine candidate, mRNA-1273, against Covid-19.
Sir Andrew Witty to co-lead WHO COVID-19 vaccine effort pharmatimes
April 17, 2020
Ex-GSK chief Sir Andrew Witty is to lead co-lead the World Health Organisation effort to speed up development of a COVID-19 vaccine.
Sinovac Biotech to move ahead with COVID-19 vaccine trial in China pharmaceutical-business-review
April 17, 2020
Sinovac Biotech has secured approval in China to move ahead with a human clinical trial on an inactivated vaccine candidate against the SARS-CoV-2 virus (novel coronavirus or COVID-19).
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing americanpharmaceuticalreview
April 17, 2020
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
HALIX and University of Oxford collaborate for GMP manufacturing of COVID-19 Vaccine expresspharma
April 17, 2020
The nCoV-19 vaccine is based on the Jenner Institute’s adenovirus vaccine vector (ChAdOx1) technology, which was chosen as the most suitable candidate for a SARS-CoV-2 (COVID-19) vaccine.
China approves two experimental coronavirus vaccines to enter clinical trials expresspharma
April 16, 2020
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
NantKwest and ImmunityBio work on Covid-19 vaccines and drugs pharmaceutical-technology
April 16, 2020
NantKwest and its sister firm ImmunityBio have partnered for the development of potential vaccines and therapeutics against Covid-19.
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests pharmaceutical-technology
April 16, 2020
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page